STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $140.06

-3.31 (-2.31%)

POWR Rating

Component Grades














  • Growth is the dimension where STAA ranks best; there it ranks ahead of 97.98% of US stocks.
  • The strongest trend for STAA is in Growth, which has been heading up over the past 47 weeks.
  • STAA ranks lowest in Value; there it ranks in the 17th percentile.

STAA Stock Summary

  • STAA's current price/earnings ratio is 328.84, which is higher than 98% of US stocks with positive earnings.
  • The price/operating cash flow metric for Staar Surgical Co is higher than 97.41% of stocks in our set with a positive cash flow.
  • Over the past twelve months, STAA has reported earnings growth of 622.03%, putting it ahead of 96.39% of US stocks in our set.
  • Stocks that are quantitatively similar to STAA, based on their financial statements, market capitalization, and price volatility, are DT, CPRX, PRLB, NXGN, and NICE.
  • Visit STAA's SEC page to see the company's official filings. To visit the company's web site, go to

STAA Valuation Summary

  • In comparison to the median Healthcare stock, STAA's price/earnings ratio is 865.48% higher, now standing at 352.4.
  • Over the past 243 months, STAA's price/sales ratio has gone up 34.6.
  • STAA's price/sales ratio has moved up 34.6 over the prior 243 months.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2021-08-31 35.5 31.2 352.4 263.8
STAA 2021-08-30 34.4 30.2 341.3 255.4
STAA 2021-08-27 33.0 29.0 327.1 244.5
STAA 2021-08-26 31.4 27.6 311.2 232.3
STAA 2021-08-25 31.0 27.3 307.7 229.7
STAA 2021-08-24 31.4 27.6 312.0 233.0

STAA Growth Metrics

  • The 5 year revenue growth rate now stands at 109.77%.
  • Its 2 year cash and equivalents growth rate is now at 433.68%.
  • Its 3 year net income to common stockholders growth rate is now at 147.01%.
STAA's revenue has moved up $88,578,000 over the prior 33 months.

The table below shows STAA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 206.198 42.287 20.778
2021-03-31 179.025 35.888 11.039
2020-12-31 163.46 20.951 5.913
2020-09-30 156.345 11.194 8.965
2020-06-30 148.319 13.399 7.461
2020-03-31 152.789 16.893 12.547

STAA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STAA has a Quality Grade of B, ranking ahead of 92.24% of graded US stocks.
  • STAA's asset turnover comes in at 0.784 -- ranking 40th of 182 Medical Equipment stocks.
  • HJLI, NURO, and BLFS are the stocks whose asset turnover ratios are most correlated with STAA.

The table below shows STAA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-02 0.784 0.764 0.341
2021-04-02 0.734 0.741 0.208
2021-01-01 0.713 0.724 0.110
2020-10-02 0.722 0.722 0.087
2020-07-03 0.720 0.722 0.056
2020-04-03 0.771 0.737 0.144

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $147.00 Average Broker Recommendation 1.5 (Moderate Buy)

STAA Stock Price Chart Interactive Chart >

Price chart for STAA

STAA Price/Volume Stats

Current price $140.06 52-week high $163.08
Prev. close $143.37 52-week low $52.66
Day low $136.92 Volume 321,461
Day high $141.95 Avg. volume 556,956
50-day MA $139.77 Dividend yield N/A
200-day MA $119.19 Market Cap 6.64B

STAAR Surgical Company (STAA) Company Bio

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.

STAA Latest News Stream

Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream

Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about Staar Surgical Co that investors may wish to consider to help them evaluate STAA as an investment opportunity.

Why Staar Surgical (STAA) Might be Well Poised for a Surge

Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | August 19, 2021

STAAR Surgical Can See Its Way Higher

In the daily bar chart of STAA, below, we can see that the shares have tripled over the past 12 months. The On-Balance-Volume (OBV) is positive but shows a small dip in July suggesting some profit-taking. In this weekly Japanese candlestick chart of STAA, below, we can see the past three years of price history.

Yahoo | August 18, 2021

These 10 Standout Stocks Could Be the Next Amazon

Companies like Amazon or Visa that can generate double-digit compound growth in revenue and earnings, year after year, are rarities. These smaller candidates could do just that.

Yahoo | August 16, 2021

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | August 13, 2021

STAA Crosses Above Common Analyst Goal

In latest buying and selling, shares of Staar Surgical Co. (Image: STAA) have crossed above the common analyst 12-month goal value of $150.00, altering palms for $155.05/share. When a inventory reaches the goal an analyst has set, the analyst logically has two methods to react: downgrade on valuation, or, re-adjust their goal value to a [] The post STAA Crosses Above Common Analyst Goal appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

FXNews24 | August 6, 2021

Read More 'STAA' Stories Here

STAA Price Returns

1-mo 7.98%
3-mo -6.18%
6-mo 47.65%
1-year 150.33%
3-year 198.32%
5-year 1,383.69%
YTD 76.80%
2020 125.25%
2019 10.22%
2018 105.87%
2017 42.86%
2016 51.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8869 seconds.